DUBLIN--(BUSINESS WIRE)--The "Global Age-Related Macular Degeneration Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
This research report provides comprehensive insights into the Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. The research analyzes and forecasts the Age-Related Macular Degeneration market size and drug sales. It also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.
Research Scope
- Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
- Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
- Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Age-Related Macular Degeneration by countries
- Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
- Age-Related Macular Degeneration drugs sales: Find out the sales value for Age-Related Macular Degeneration drugs by countries
- Age-Related Macular Degeneration market valuations: Find out the market size for Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
- Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research
- Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in the Age-Related Macular Degeneration market
- Develop in-depth knowledge of competition and markets
- Analyze Age-Related Macular Degeneration drug sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track Market Events and Trends and analyze key events in the Age-Related Macular Degeneration market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
Key Topics Covered
1. Age-Related Macular Degeneration Treatment Options
2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Age-Related Macular Degeneration Epidemiology Analysis by Countries
4. US Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Age-Related Macular Degeneration in US
4.2. US Age-Related Macular Degeneration Market Size & Forecast
4.3. US Age-Related Macular Degeneration Drugs Sales & Forecast
4.4. US Age-Related Macular Degeneration Market Share Analysis
5. Germany Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Age-Related Macular Degeneration in Germany
5.2. Germany Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Age-Related Macular Degeneration Drugs Sales Forecast
5.4. Germany Age-Related Macular Degeneration Market Share Analysis
6. France Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Age-Related Macular Degeneration in France
6.2. France Age-Related Macular Degeneration Market Size & Forecast
6.3. France Age-Related Macular Degeneration Product Sales Forecast
6.4. France Age-Related Macular Degeneration Market Share Analysis
7. Italy Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Age-Related Macular Degeneration in Italy
7.2. Italy Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Age-Related Macular Degeneration Market Share Analysis
8. Spain Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Age-Related Macular Degeneration in Spain
8.2. Spain Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Age-Related Macular Degeneration Market Share Analysis
9. UK Age-Related Macular Degeneration Market Insights
9.1. Marketed Drugs for Age-Related Macular Degeneration in UK
9.2. UK Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Age-Related Macular Degeneration Market Share Analysis
10. Europe Age-Related Macular Degeneration Market Insights
10.1. Europe Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Age-Related Macular Degeneration Market Share Analysis
11. Japan Age-Related Macular Degeneration Market Insights
11.1. Marketed Drugs for Age-Related Macular Degeneration in Japan
11.2. Japan Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Age-Related Macular Degeneration Market Share Analysis
12. Global Age-Related Macular Degeneration Market Insights
12.1. Global Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Age-Related Macular Degeneration Market Share Analysis
For more information about this report visit https://www.researchandmarkets.com/r/clq6j2
